<div class=”MsoNormal” style=”color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px; line-height: 19.8px; text-align: justify;”><span lang=”EN-US” style=”font-family: arial, sans-serif; font-size: 10pt; line-height: 20px;”>A CV is a glimpse into the life of a professional. For any given job vacancy, it is…[Read more]

http://pharmaliterati.blogspot.in/2016/03/future-of-drugs-diabetesbexagliflozin.html

Learn more about Bexagliflozin by Theracos

http://pharmaliterati.blogspot.in/2016/03/future-of-drugs-diabeteslik-066.html

Learn more about LIK-066 by Novartis

http://pharmaliterati.blogspot.in/2016/03/future-of-drugs-diabetesertugliflozin.html

Read about Ertugliflozin from Pfizer and Merck

Every week of thousands of patent applications are published in India. The patent applications filed by the pharma academic research institutes in India go un-noticed.

We publish a list of Indian applications published related to pharma academics. This would provide us an idea about the kind of academic research being carried out in these…[Read more]